Searched for
ABBOTT INDIA RESULTS
India's protein supplements market reaches $912.9 million in 2025 as demand grows for gut-friendly, additive-free formulationsMumbai (Maharashtra) [India], India's protein supplements market reached approximately USD $912.9 million in 2025, according to IMARC Group...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36%Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Abbott India Q2 results: Net profit up 6% to Rs 192 croreRevenue from operations stood at Rs 1,222.06 crore for the quarter under consideration.
- Abbott India Q1 results: Net profit rises 8.5% to Rs 196 crThe company had posted a net profit of Rs 180.35 crore for the corresponding period of the previous fiscal, Abbott India said in a regulato...
- Abbott India Q4 results: Net profit up 37% at Rs 152 croreRevenue from operations of the company stood at Rs 1,095.54 crore for the quarter under consideration. It was Rs 961.20 crore for the same ...
- Abbott India Q3 results: Net profit falls 5% to Rs 177 crThe consolidated revenue from operations of the company stood at Rs 1,095.37 crore for the quarter under consideration.
- Abbott India gains 19% as parent firm gets approval for Covid-19 testAbbott said in a statement that it plans to begin distributing the test next week and will ramp up manufacturing to 50,000 tests per day.
- Abbott India Q2 profit rises 30% to Rs 178 croreThe company had posted a profit of Rs 137.68 crore for the year-ago period.
- Abbott India Q1 profit up 42% to Rs 117 croreTotal income for the quarter under review rose to Rs 1,028.49 crore as against Rs 866.68 crore for the same period a year ago.
- Abbott jumps on to digital health service bandwagonAbbott will also look at partnering with e-pharmacies, diagnostic chains and physicians to provide patients with discounts.
- Hold Abbott India Ltd., target Rs 4480.0 : Centrum BrokingThe brokerage said it reported 16% YoY growth in revenues, 50 bps decline in margin to 14.3% and 10% YoY growth in net profit.
- Australia PM Tony Abbott survives confidence voteAbbott said he took the result of today's leadership spill motion, which was defeated by 61 - 39, as a "shot across his bow".
- Mylan-Abbott deal gets CCI green signalThe CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...
- G20 will be focused on removing International barriers to trade:Aus PM Tony AbbottAbbott also highlighted his government's effort to fast-track free trade agreements with South Korea, Japan, China, Indonesia and India to ...
- India-Australia ties likely to get boost under PM-elect Tony AbbottAustralia-India ties will become more robust under Prime Minister-elect Tony Abbott, who had once described India as an emerging super powe...
- Abbott India Q1 net profit at Rs 27.08 croreAbbott India today said it has posted a net profit of Rs 27.08 crore for the quarter ended March 31, 2012 over the same period of previous ...
- Abbott India posts net of Rs 5.94 croreThe company had a net profit of Rs 11.80 crore for the quarter ended February 28, 2010, Abbott India said in a filing to the Bombay Stock E...
- Abbott yet to reap benefits of Piramal buyThe purchase of Piramal Healthcare's domestic formulations biz by Abbott Lab has changed little on the ground for the foreign company even ...
Load More
